We are live on ! Find out more
MDT icon

Medtronic

2,080 hedge funds and large institutions have $89.9B invested in Medtronic in 2023 Q4 according to their latest regulatory filings, with 273 funds opening new positions, 652 increasing their positions, 991 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

102% more first-time investments, than exits

New positions opened: 273 | Existing positions closed: 135

5% more funds holding

Funds holding: 1,972 → 2,080 (+108)

3% more funds holding in top 10

Funds holding in top 10: 31 → 32 (+1)

5% more call options, than puts

Call options by funds: $847M | Put options by funds: $807M

0.06% less ownership

Funds ownership: 82.11% → 82.05% (-0.06%)

0% less capital inflows, than outflows

Capital inflows: $4.19B | Capital outflows: $4.19B

34% less repeat investments, than reductions

Existing positions increased: 652 | Existing positions reduced: 991

Holders
2,080
Holders Change
+108
Holders Change %
+5.48%
% of All Funds
30.23%
Holding in Top 10
32
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+3.23%
% of All Funds
0.47%
New
273
Increased
652
Reduced
991
Closed
135
Calls
$847​M
Puts
$807​M
Net Calls
+$39.9​M
Net Calls Change
-⁠$166​M

MDT Hedge Fund Activity: Q4 2023 in Review

2,080 of the 6,880 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q4 2023, worth a combined $89.9B — up 5% from $85.6B a quarter earlier.

Buyers outnumbered sellers: 273 funds opened new MDT positions and 135 closed out — a net gain of 138 holders — while 652 added to existing stakes and 991 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $421M. The largest seller was Ameriprise, cutting an estimated $379M.

  • 2,080 institutional investors held Medtronic (MDT) as of Q4 2023, up from 1,972 in Q3 2023.
  • Funds reported $89.9B of Medtronic stock for Q4 2023, up 5% quarter-over-quarter.
  • 273 funds opened new Medtronic positions in Q4 2023 and 135 closed out, a net change of +138 holders.
  • The largest Medtronic buyer in Q4 2023 was JP Morgan Chase, an estimated $421M added.
  • The largest Medtronic seller in Q4 2023 was Ameriprise, an estimated $379M sold.

Based on aggregated 13F filings for Q4 2023.